CIK 0001501697
- Non-accelerated filer
- Smaller reporting company
X4 Pharmaceuticals, Inc
Sign in to watch- Ticker
- XFOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273181608
- Phone
- +1 857-529-8300
- Business address
- 61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
- Former names
- Arsanis, Inc.
- Open-market buys, last 90 days
- $11,884
- in 1 filing
- Open-market sales, last 90 days
- $33,658
- in 1 filing
Net −$21,775. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-24 | Meisner Derek M Chief Legal Officer | Sale | −4,166 | 153,489 | ||
| 2022-06-16 | Mostafa Adam S. Chief Financial Officer | Sale | −5,416 | 192,808 | ||
| 2022-06-16 | Ragan Paula President and CEO | Sale | −6,724 | 655,082 | ||
| 2022-06-16 | DiBiase Mary Chief Operating Officer | Sale | −856 | 182,043 | ||
| 2022-06-16 | Meisner Derek M Chief Legal Officer | Sale | −4,166 | 157,655 | ||
| 2022-06-06 | Bridger Gary Director | Grant or award | +6,667 | 6,667 | ||
| 2022-06-06 | Lawton Alison Frances Director | Grant or award | +6,667 | 6,667 | ||
| 2022-06-06 | WYZGA MICHAEL S Director | Grant or award | +6,667 | 6,667 | ||
| 2022-06-06 | de Craecker Francoise Director | Grant or award | +6,667 | 6,667 | ||
| 2022-06-06 | Stewart Murray Director | Grant or award | +6,667 | 6,667 | ||
| 2022-06-06 | Aliski William Director | Grant or award | +6,667 | 6,667 | ||
| 2022-06-06 | MCGIRR DAVID W J Director | Grant or award | +6,667 | 6,667 | ||
| 2022-06-03 | Ragan Paula President and CEO | Sale | −6,292 | $1.21 | $8K | 661,806 |
| 2022-03-01 | DiBiase Mary Chief Operating Officer | Grant or award | +105,000 | 182,899 | ||
| 2022-03-01 | Ragan Paula President and CEO | Grant or award | +220,789 | 668,098 | ||
| 2022-03-01 | Taveras Arthur Chief Scientific Officer | Grant or award | +97,000 | 104,107 | ||
| 2022-03-01 | Mostafa Adam S. Chief Financial Officer | Grant or award | +105,000 | 198,224 | ||
| 2022-03-01 | Cadavid Diego Chief Medical Officer | Grant or award | +97,000 | 104,107 | ||
| 2022-03-01 | Meisner Derek M Chief Legal Officer | Grant or award | +105,000 | 161,821 | ||
| 2022-02-11 | Mostafa Adam S. Chief Financial Officer | Sale | −27,721 | 93,224 |
Page 8 of 25 · 490 trades